Invention Grant
- Patent Title: Tissue targeted antigenic activation of the immune response to treat cancers
-
Application No.: US14800314Application Date: 2015-07-15
-
Publication No.: US09775896B2Publication Date: 2017-10-03
- Inventor: Harold David Gunn
- Applicant: Qu Biologics Inc.
- Applicant Address: CA Vancouver
- Assignee: Qu Biologics Inc.
- Current Assignee: Qu Biologics Inc.
- Current Assignee Address: CA Vancouver
- Agency: Bozicevic, Field & Francis LLP
- Agent Shweta Chandra; Bret E. Field
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/085 ; A61K39/09 ; A61K39/235 ; A61K31/405 ; A61K31/635 ; A61K31/192 ; A61K39/108 ; A61K39/112 ; A61K39/104 ; A61K33/24 ; A61K39/02 ; A61K39/102 ; A61K39/145 ; A61K39/155 ; G01N33/50 ; C12R1/445
Abstract:
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Public/Granted literature
- US20150343050A1 Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers Public/Granted day:2015-12-03
Information query
